Created at Source Raw Value Validated value
June 25, 2024, noon usa

inclusion criteria: the participants can be enrolled only all of the following criteria are met: 1. voluntarily participate in this study and sign the informed consent form; 2. adults aged 18 years and older, male or female; 3. according to the assessment of the investigator, the participant has a stable medical condition (which is defined as no significant changes in therapy or hospitalization caused by disease aggravation within 3 months before enrollment) and is able to and willing to follow the requirements of the protocol. 4. males of reproductive potential and females of child-bearing potential voluntarily agree to take effective and acceptable contraceptive methods from the signing of informed consent form to 12 months after full-course immunization; females of child-bearing potential have a negative pregnancy test at screening and at the day of vaccination.

inclusion criteria: the participants can be enrolled only all of the following criteria are met: 1. voluntarily participate in this study and sign the informed consent form; 2. adults aged 18 years and older, male or female; 3. according to the assessment of the investigator, the participant has a stable medical condition (which is defined as no significant changes in therapy or hospitalization caused by disease aggravation within 3 months before enrollment) and is able to and willing to follow the requirements of the protocol. 4. males of reproductive potential and females of child-bearing potential voluntarily agree to take effective and acceptable contraceptive methods from the signing of informed consent form to 12 months after full-course immunization; females of child-bearing potential have a negative pregnancy test at screening and at the day of vaccination.

Nov. 16, 2021, 6:30 p.m. usa

inclusion criteria: the participants can be enrolled only all of the following criteria are met: voluntarily participate in this study and sign the informed consent form; adults aged 18 years and older, male or female; according to the assessment of the investigator, the participant has a stable medical condition (which is defined as no significant changes in therapy or hospitalization caused by disease aggravation within 3 months before enrollment) and is able to and willing to follow the requirements of the protocol. males of reproductive potential and females of child-bearing potential voluntarily agree to take effective and acceptable contraceptive methods from the signing of informed consent form to 12 months after full-course immunization; females of child-bearing potential have a negative pregnancy test at screening and at the day of vaccination.

inclusion criteria: the participants can be enrolled only all of the following criteria are met: voluntarily participate in this study and sign the informed consent form; adults aged 18 years and older, male or female; according to the assessment of the investigator, the participant has a stable medical condition (which is defined as no significant changes in therapy or hospitalization caused by disease aggravation within 3 months before enrollment) and is able to and willing to follow the requirements of the protocol. males of reproductive potential and females of child-bearing potential voluntarily agree to take effective and acceptable contraceptive methods from the signing of informed consent form to 12 months after full-course immunization; females of child-bearing potential have a negative pregnancy test at screening and at the day of vaccination.

Oct. 28, 2021, 11 a.m. usa

inclusion criteria: the participants can be enrolled only all of the following criteria are met: 1. voluntarily participate in this study and sign the informed consent form; 2. adults aged 18 years and older, male or female; 3. according to the assessment of the investigator, the participant has a stable medical condition (which is defined as no significant changes in therapy or hospitalization caused by disease aggravation within 3 months before enrollment) and is able to and willing to follow the requirements of the protocol. 4. males of reproductive potential and females of child-bearing potential voluntarily agree to take effective and acceptable contraceptive methods from the signing of informed consent form to 12 months after full-course immunization; females of child-bearing potential have a negative pregnancy test at screening and at the day of vaccination.

inclusion criteria: the participants can be enrolled only all of the following criteria are met: 1. voluntarily participate in this study and sign the informed consent form; 2. adults aged 18 years and older, male or female; 3. according to the assessment of the investigator, the participant has a stable medical condition (which is defined as no significant changes in therapy or hospitalization caused by disease aggravation within 3 months before enrollment) and is able to and willing to follow the requirements of the protocol. 4. males of reproductive potential and females of child-bearing potential voluntarily agree to take effective and acceptable contraceptive methods from the signing of informed consent form to 12 months after full-course immunization; females of child-bearing potential have a negative pregnancy test at screening and at the day of vaccination.